Saroja Pharma Industries India Ltd. (SAROJA.NS) Comparison with companies in other sectors?

Saroja Pharma Industries India Ltd. has a share price of 4.02M. You can analyze Saroja Pharma Industries India Ltd. (SAROJA.NS) competitors across different market sectors through stock heatmaps.

What are SAROJA.NS's NET and operating margins?

Saroja Pharma Industries India Ltd. (SAROJA.NS) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does SAROJA.NS's earnings per share (EPS) trend reflect its financial momentum?

Saroja Pharma Industries India Ltd. (SAROJA.NS) EPS is 2.57 (If EPS value is positive, then "signals consistent profit growth" if Negative then "signals consistent loss"). This metric is also critical in assessing valuation metrics like the P/E ratio for Saroja Pharma Industries India Ltd. is 10.89, and the company's ability to reinvest or distribute profits.

What does a high ROE mean for Saroja Pharma Industries India Ltd.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Saroja Pharma Industries India Ltd. like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

Saroja Pharma Industries India Ltd.

SAROJA.NS•NSE

Industrials

Industrial - Distribution

₹29.40

₹0.05(0.17%)

Indian Market opens in 10h 19m

Saroja Pharma Industries India Ltd. Fundamental Analysis

Saroja Pharma Industries India Ltd. (SAROJA.NS) shows weak financial fundamentals with a PE ratio of 10.89, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze SAROJA.NS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

0.0/100

We analyze SAROJA.NS's fundamental strength across five key dimensions:

Efficiency Score

Weak

SAROJA.NS struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Moderate

SAROJA.NS shows balanced valuation metrics.

PE < 25

10.89

PEG Ratio < 2

N/A

Growth Score

Moderate

SAROJA.NS shows steady but slowing expansion.

Revenue Growth > 5%

N/A

EPS Growth > 10%

N/A

Financial Health Score

Weak

SAROJA.NS carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

SAROJA.NS struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is SAROJA.NS Expensive or Cheap?

P/E Ratio

SAROJA.NS trades at 10.89 times earnings. This suggests potential undervaluation.

10.89

How Well Does SAROJA.NS Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How SAROJA.NS Stacks Against Its Sector Peers

Metric	SAROJA.NS Value	Sector Average	Performance
P/E Ratio	N/A	25.55	N/A
ROE	N/A	1262.00%	N/A
Net Margin	N/A	-42065.00% (disorted)	N/A
Debt/Equity	N/A	0.79	N/A
Current Ratio	N/A	10.09	N/A
ROA	N/A	-1502268.00% (disorted)	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Saroja Pharma Industries India Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Cyclical, Value, Infrastructure

EPS CAGR

N/A

Industry Style: Cyclical, Value, Infrastructure

FCF CAGR

N/A

Industry Style: Cyclical, Value, Infrastructure

Saroja Pharma Industries India Ltd. Fundamental Analysis

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is SAROJA.NS Expensive or Cheap?

How Well Does SAROJA.NS Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How SAROJA.NS Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

Saroja Pharma Industries India Ltd. (SAROJA.NS) Comparison with companies in other sectors?

What are SAROJA.NS's NET and operating margins?

In what way does SAROJA.NS's earnings per share (EPS) trend reflect its financial momentum?

What does a high ROE mean for Saroja Pharma Industries India Ltd.?

How do I know if AAPL is overvalued or undervalued?